Reckitt Benckiser (Switzerland) AG
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- GAVISCON DUAL chewable tablet 350 mg+100 mg+120 mg
- GAVISCON DUAL LIQUID oral suspension 500 mg/5 ml+100 mg/5 ml+100 mg/5 ml+5 mg/5 ml
- GAVISCON ERDBEER chewable tablet 350 mg+100 mg+120 mg
- GAVISCON LIQUID MINT SACHET oral suspension 500 mg/5 ml+100 mg/5 ml+100 mg/5 ml+5 mg/5 ml
- GAVISCON MINT chewable tablet 350 mg+100 mg+120 mg
- GAVISCONELL DUAL LIQUID oral suspension 500 mg/5 ml+213 mg/5 ml
- GAVISCONELL LIQUID MINT oral suspension 500 mg/5 ml+267 mg/5 ml
- M01 - Antiinflamatorios y antirreumáticos
- NUROFEN DOLO coated tablet 200 mg
- NUROFEN DOLO JUNIOR ERDBEER oral suspension 100 mg/5 ml
- NUROFEN JUNIOR FORTE ERDBEER oral suspension 200 mg/5 ml
- R02 - Preparados para la garganta
- STREPSILS DOLO MIEL CITRON lozenge 8.75 mg
- STREPSILS DOLO SANS SUCRE ORANGE lozenge 8.75 mg
- STREPSILS DOLO SPRAY oromucosal spray 8.75 mg/dose
- STREPSILS MIEL CITRON lozenge 1.2 mg
- STREPSILS SANS SUCRE FRAISE lozenge 1.2 mg